Myriad Neuroscience

Myriad Neuroscience company information, Employees & Contact Information

Myriad Neuroscience--formerly Assurex Health--is a personalized medicine company that specializes in pharmacogenomics and is dedicated to helping healthcare providers get the genetic information they need to determine the right medication for individual patients suffering from neuropsychiatric and other medical conditions. Myriad Neuroscience’s proprietary technology is based on pharmacogenomics—the study of the genetic factors that influence an individual’s response to drug treatments—as well as evidence-based medicine and clinical pharmacology. The GeneSight® test was developed in the Myriad Neuroscience clinical laboratory and is based on patented technology licensed from two world renowned medical centers, Mayo Clinic and Cincinnati Children’s Hospital Medical Center, who continue to be research collaborators. The company was founded in 2006 and is located in Mason, OH.

Company Details

Employees
108
Founded
-
Address
6960 Cintas Blvd, Mason,oh 45040,united States
Phone
(866) 757-9204
Email
su****@****lth.com
Industry
Mental Health Care
NAICS
Offices of Mental Health Practitioners (except Physicians)
HQ
Mason, OH
Looking for a particular Myriad Neuroscience employee's phone or email?

Myriad Neuroscience Questions

News

New Meta-Analysis Demonstrates that Access to the GeneSight - GlobeNewswire

New Meta-Analysis Demonstrates that Access to the GeneSight GlobeNewswire

GeneSight Test & Mental Health - WKEF

GeneSight Test & Mental Health WKEF

41% Higher Depression Remission: Myriad Genetics' GeneSight Test Proves Superior in 3,500+ Patient Study - Stock Titan

41% Higher Depression Remission: Myriad Genetics' GeneSight Test Proves Superior in 3,500+ Patient Study Stock Titan

Breaking barriers in senior mental health - WCPO 9 News

Breaking barriers in senior mental health WCPO 9 News

Myriad Genetics Study Finds GeneSight Test Reduces Psychiatric Hospitalizations in Major Depressive Disorder Patients - Nasdaq

Myriad Genetics Study Finds GeneSight Test Reduces Psychiatric Hospitalizations in Major Depressive Disorder Patients Nasdaq

Myriad Genetics Engages with UnitedHealthcare on Access to GeneSight Test Following Policy Update - Quiver Quantitative

Myriad Genetics Engages with UnitedHealthcare on Access to GeneSight Test Following Policy Update Quiver Quantitative

Why Seniors Must Speak Up About Mental Health: Patient and Clinician Share Insights on YourUpdateTV - The Manila Times

Why Seniors Must Speak Up About Mental Health: Patient and Clinician Share Insights on YourUpdateTV The Manila Times

Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status - Yahoo Finance

Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status Yahoo Finance

Myriad’s GeneSight test proves effective in new study data - Clinical Trials Arena

Myriad’s GeneSight test proves effective in new study data Clinical Trials Arena

GeneSight mental health monitor reveals gap on the front line of mental health care - EurekAlert!

GeneSight mental health monitor reveals gap on the front line of mental health care EurekAlert!

Mayo Clinic receives patent for GeneSight - McKnight's Long-Term Care News

Mayo Clinic receives patent for GeneSight McKnight's Long-Term Care News

This Genetic Test Saved My Life When Hope Was Lost - Women's Health

This Genetic Test Saved My Life When Hope Was Lost Women's Health

Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing - Stock Titan

Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing Stock Titan

Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing - GlobeNewswire

Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing GlobeNewswire

MYGN's GeneSight Test Proven Superior to TAU: Stock to Gain? - Yahoo Finance

MYGN's GeneSight Test Proven Superior to TAU: Stock to Gain? Yahoo Finance

'Happy, healthy and focused' | DNA testing in Mason helps patients find mental health medications faster - WCPO 9 News

'Happy, healthy and focused' | DNA testing in Mason helps patients find mental health medications faster WCPO 9 News

MYGN Q1 Earnings Call: Guidance Cut Amid GeneSight Challenges and Slow Hereditary Cancer Ramp - Yahoo Finance

MYGN Q1 Earnings Call: Guidance Cut Amid GeneSight Challenges and Slow Hereditary Cancer Ramp Yahoo Finance

Myriad Launches New GeneSight® Psychotropic Patient Collection Kit - GlobeNewswire

Myriad Launches New GeneSight® Psychotropic Patient Collection Kit GlobeNewswire

77% of Americans have used addictive behaviors or unhealthy coping mechanisms to manage their mental health, according to Myriad Genetics nationwide survey - Yahoo Finance

77% of Americans have used addictive behaviors or unhealthy coping mechanisms to manage their mental health, according to Myriad Genetics nationwide survey Yahoo Finance

Depression Disconnect: Study shows lack of understanding and empathy about depression - WKYC

Depression Disconnect: Study shows lack of understanding and empathy about depression WKYC

Suffering in Silence: Two-Thirds of Seniors Say They Won’t Treat Their Depression - SciTechDaily

Suffering in Silence: Two-Thirds of Seniors Say They Won’t Treat Their Depression SciTechDaily

New Study Finds Assurex Health's GeneSight CPGxTM Precision Medicine Test Provides Significant Health Care Cost Savings - PRWeb

New Study Finds Assurex Health's GeneSight CPGxTM Precision Medicine Test Provides Significant Health Care Cost Savings PRWeb

UnitedHealth update ‘not the end’ for Myriad’s GeneSight, says Raymond James - Nasdaq

UnitedHealth update ‘not the end’ for Myriad’s GeneSight, says Raymond James Nasdaq

UnitedHealthcare limits coverage for Myriad's GeneSight test - Investing.com

UnitedHealthcare limits coverage for Myriad's GeneSight test Investing.com

Pioneering genetic-testing company Myriad's biggest up-and-coming product could be at risk after scientists raised major questions - businessinsider.com

Pioneering genetic-testing company Myriad's biggest up-and-coming product could be at risk after scientists raised major questions businessinsider.com

Mental Health: Why so many women are at their breaking point - WKYC

Mental Health: Why so many women are at their breaking point WKYC

Myriad board, execs face Del suit over 'misleading' genetic test statements - Reuters

Myriad board, execs face Del suit over 'misleading' genetic test statements Reuters

Assurex Health Passes Quarter Million Patients Tested with GeneSight® - PR Newswire

Assurex Health Passes Quarter Million Patients Tested with GeneSight® PR Newswire

Myriad Genetics Faces Risk After FDA Asks for GeneSight Test Changes - businessinsider.com

Myriad Genetics Faces Risk After FDA Asks for GeneSight Test Changes businessinsider.com

Myriad Genetics plummets 20% as UnitedHealth changes GeneSight coverage - Seeking Alpha

Myriad Genetics plummets 20% as UnitedHealth changes GeneSight coverage Seeking Alpha

'You need to have the conversation': More primary care clinics are offering a range of mental health support - MinnPost

'You need to have the conversation': More primary care clinics are offering a range of mental health support MinnPost

Weighing the Benefits of Genetic Information in Clinical Psychiatry - Psychiatric Times

Weighing the Benefits of Genetic Information in Clinical Psychiatry Psychiatric Times

Kroger Prescription Plans Partners with Myriad Genetics to Offer GeneSight Genetic Tests and Genetic Counseling in Kroger Pharmacies - Dark Daily

Kroger Prescription Plans Partners with Myriad Genetics to Offer GeneSight Genetic Tests and Genetic Counseling in Kroger Pharmacies Dark Daily

New Psychiatric DNA Testing Is Unproven Ground - NBC News

New Psychiatric DNA Testing Is Unproven Ground NBC News

Assurex Health Enhances Clinically Proven Genetic Test to Help Healthcare Providers Choose Psychiatric Medications for Patients - PRWeb

Assurex Health Enhances Clinically Proven Genetic Test to Help Healthcare Providers Choose Psychiatric Medications for Patients PRWeb

Depression Disconnect: New Survey Finds Most People with Depression Feel Deeply Misunderstood - pottsmerc.com

Depression Disconnect: New Survey Finds Most People with Depression Feel Deeply Misunderstood pottsmerc.com

Myriad Genetics Faces Cost Restructuring As UnitedHealthcare Ends GeneSight Coverage, Appoints New CEO - Benzinga

Myriad Genetics Faces Cost Restructuring As UnitedHealthcare Ends GeneSight Coverage, Appoints New CEO Benzinga

Genes hold the key - Psychology Today

Genes hold the key Psychology Today

Back-To-School is Appropriate Time to Evaluate ADHD Medication Choice - PRWeb

Back-To-School is Appropriate Time to Evaluate ADHD Medication Choice PRWeb

Top Myriad Neuroscience Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant